CTS2190

· CytosinLab Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTS2190, covering 2024-08-23 to 2024-08-23. Get the full timeline:

Most recent: Clinical Trial Update: CTS2190 Phase I /II Clinical Study in Patients [Phase 1, Phase 2]